Candida vulvovaginitis cost-effectiveness of therapy: Difference between revisions

	Candida vulvovaginitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Candidiasis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
Other Imagining Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Candida vulvovaginitis cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Candida vulvovaginitis cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Candida vulvovaginitis cost-effectiveness of therapy
CDC on Candida vulvovaginitis cost-effectiveness of therapy
Candida vulvovaginitis cost-effectiveness of therapy in the news
Blogs on Candida vulvovaginitis cost-effectiveness of therapy
Directions to Hospitals Treating Candidiasis
Risk calculators and risk factors for Candida vulvovaginitis cost-effectiveness of therapy

Revision as of 17:18, 18 September 2017

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

@@ Line 8: / Line 8: @@
 [[Category:Needs content]]
-[[Category:Infectious disease]]
 [[Category:Nephrology]]
 [[Category:Dermatology]]
@@ Line 21: / Line 21: @@
 [[Category:Primary care]]
 [[Category:Up-To-Date]]
-[[Category:Infectious disease]]
 [[Category:Gynecology]]
 [[Category:Obstetrics]]